7-11-1　ⓔ文献

  1. WHO: Global trends in the burden of malaria. World Malaria Report 2020, WHO Press, 2020; 18–37.

  2. Singh B, Sung LK, et al: A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet, 2004; 363: 1017–1024.

  3. Tanizaki R, Ujiie M, et al: First case of Plasmodium knowlesi infection in a Japanese traveller returning from Malaysia. Malar J, 2013; 12: 128.

  4. Kantele A, Jokiranta TS: Review of cases with the emerging fifth human malaria parasite, Plasmodium knowlesi. Clin Infect Dis, 2011; 52: 1356–1362.

  5. Cox-Singh J, Hiu J, et al: Severe malaria–a case of fatal Plasmodium knowlesi infection with post–mortem findings: a case report. Malar J, 2010; 9: 10.

  6. Ménard D, Khim N, et al: A worldwide map of Plasmodium falciparum K13–propeller polymorphisms. N Engl J Med, 2016; 374: 2453–2464.

  7. Jelinek T, Nothdurft HD, et al: Malaria in nonimmune travelers: a synopsis of history, symptoms and treatment in 160 patients. J Travel Med, 1994; 1: 199–202.

  8. Global Malaria Programme: Treatment of severe malaria. Guideline for the treatment of malaria, 3rd ed, WHO, 2015; 71–88.

  9. Kano S: Artemisinin–based combination therapies and their introduction in Jpan. J Infect Chemother, 2010; 16: 175–182.

  10. 海老沢功，田辺清勝，他：熱帯熱マラリア治療における開始遅延の意義．Jpn J Trop Med Hyg, 1991; 19: 49–56.

  11. 狩野繁之：マラリア予防ガイドラインの概要．Clin Parasitol, 2006; 17: 25–27.